CRYSTAL LAKE, IL—Hedi Tlili, Segment President at Aptargroup, Inc. (NYSE:ATR), has sold 3,614 shares of the company’s common stock, according to a recent SEC filing. The shares were sold on May 16 at a weighted average price of approximately $155.96, totaling $563,642. The transaction occurred as the stock trades near $157, with InvestingPro analysis indicating the stock is currently fairly valued. The company, with a market capitalization of $10.3 billion, maintains a "GREAT" financial health score. Following this transaction, Tlili retains ownership of 9,379 shares in the company.
The shares were sold in multiple transactions, with prices ranging from $155.50 to $156.23. The sale was executed directly by Tlili, as indicated in the filing.
In other recent news, AptarGroup, Inc. reported its first-quarter earnings for 2025, showing a modest beat in earnings per share (EPS) while falling short on revenue expectations. The company’s adjusted EPS was $1.20, surpassing the anticipated $1.16, but revenue came in at $887 million, missing the forecasted $929.07 million. The Pharma segment demonstrated strong performance with a 3% increase in core sales. Alongside these financial results, AptarGroup announced the expansion of its 2018 Equity Incentive Plan, increasing the number of shares available for issuance by 1,000,000 following stockholder approval. During the same annual meeting, three directors were elected, and PricewaterhouseCoopers LLP was appointed as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The company’s executive compensation plan also received advisory approval from stockholders. AptarGroup continues to focus on innovation, with new product launches in Germany and China, and plans to conduct a clinical validation study for its Smartrac services platform. Looking forward, AptarGroup provided guidance for Q2 2025, expecting an EPS range of $1.56 to $1.64.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.